Total Payments
$1,427
2024 Payments
$107.56
Companies
15
Transactions
31
Medicare Patients
2,246
Medicare Billing
$167,429
Payment Breakdown by Category
Food & Beverage$1,427 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,427 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $273.77 | 6 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $253.54 | 4 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $210.79 | 3 | $0 (2017) |
| Shire North American Group Inc | $136.85 | 2 | $0 (2018) |
| Alcon Laboratories Inc | $121.90 | 1 | $0 (2017) |
| CooperVision Inc. | $94.68 | 1 | $0 (2018) |
| Horizon Therapeutics plc | $65.48 | 3 | $0 (2023) |
| Johnson & Johnson Vision Care, Inc. | $61.08 | 2 | $0 (2024) |
| Amgen Inc. | $50.41 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $34.06 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $107.56 | 4 | Amgen Inc. ($50.41) |
| 2023 | $116.16 | 5 | Horizon Therapeutics plc ($65.48) |
| 2022 | $85.04 | 4 | Allergan, Inc. ($40.20) |
| 2020 | $15.96 | 1 | Alcon Vision LLC ($15.96) |
| 2019 | $249.73 | 4 | Allergan Inc. ($111.30) |
| 2018 | $504.03 | 8 | Bausch & Lomb, a division of Bausch Health US, LLC ($147.39) |
| 2017 | $348.91 | 5 | Valeant Pharmaceuticals North America LLC ($210.79) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/05/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $28.80 | General |
| 02/26/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: EYE CARE | ||||||
| 02/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/21/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Ophthalmology | ||||||
| 08/18/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $34.06 | General |
| 06/04/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: TEPEZZA | ||||||
| 04/12/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: TEPEZZA | ||||||
| 03/01/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: TEPEZZA | ||||||
| 05/18/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Ophthalmology | ||||||
| 05/11/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/18/2022 | Allergan, Inc. | VUITY (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/10/2022 | Allergan, Inc. | VUITY (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/16/2020 | Alcon Vision LLC | DAILIES (Device) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Ophthalmology | ||||||
| 12/05/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | ULTRA (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $90.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/05/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | ULTRA (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/10/2019 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $111.30 | General |
| Category: DRY EYE | ||||||
| 03/22/2019 | Johnson & Johnson Vision Care, Inc. | Acuvue (Device) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: Soft Contact Lenses | ||||||
| 09/24/2018 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: DRY EYE | ||||||
| 09/19/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $120.63 | General |
| Category: OPTHALMICS | ||||||
| 09/10/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Ophthalmology | ||||||
| 06/26/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | ULTRA (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $56.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/25/2018 | CooperVision Inc. | Multiple Brands Contact Lens (Device) | Food and Beverage | In-kind items and services | $94.68 | General |
| Category: Devices | ||||||
| 06/05/2018 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $94.52 | General |
| Category: DRY EYE | ||||||
| 06/05/2018 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: DRY EYE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 640 | 671 | $208,174 | $49,184 |
| 2022 | 7 | 415 | 432 | $135,836 | $28,493 |
| 2021 | 7 | 641 | 691 | $213,439 | $51,411 |
| 2020 | 9 | 550 | 582 | $176,258 | $38,342 |
Total Patients
2,246
Total Services
2,376
Medicare Billing
$167,429
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 270 | 270 | $98,820 | $23,888 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 98 | $30,478 | $9,328 | 30.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 59 | 59 | $25,842 | $5,724 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 64 | $13,632 | $4,241 | 31.1% |
| 92250 | Photography of the retina | Office | 2023 | 99 | 99 | $24,200 | $2,744 | 11.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 15 | 15 | $3,795 | $1,129 | 29.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 20 | 20 | $5,943 | $1,020 | 17.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 22 | 23 | $3,168 | $656.37 | 20.7% |
| 92134 | Imaging of retina | Office | 2023 | 12 | 12 | $1,680 | $365.40 | 21.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 11 | 11 | $616.00 | $88.55 | 14.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 206 | 207 | $75,762 | $17,048 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 45 | $13,995 | $3,934 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 44 | $9,372 | $2,288 | 24.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 30 | 30 | $13,140 | $2,255 | 17.2% |
| 92250 | Photography of the retina | Office | 2022 | 78 | 79 | $18,040 | $2,213 | 12.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 13 | 13 | $3,679 | $428.77 | 11.7% |
| 92133 | Imaging of optic nerve | Office | 2022 | 14 | 14 | $1,848 | $325.61 | 17.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 306 | 306 | $111,996 | $27,377 | 24.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 79 | $24,569 | $7,429 | 30.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 104 | $22,152 | $7,127 | 32.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 46 | 46 | $20,148 | $4,437 | 22.0% |
| 92250 | Photography of the retina | Office | 2021 | 120 | 124 | $27,500 | $3,818 | 13.9% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 17 | 17 | $5,094 | $813.51 | 16.0% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 13 | 15 | $1,980 | $408.55 | 20.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 266 | 266 | $97,356 | $22,507 | 23.1% |
About Dr. Donna Vann, O.D
Dr. Donna Vann, O.D is a Optometrist healthcare provider based in Wakefield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2011. The National Provider Identifier (NPI) number assigned to this provider is 1902188477.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donna Vann, O.D has received a total of $1,427 in payments from pharmaceutical and medical device companies, with $107.56 received in 2024. These payments were reported across 31 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,427).
As a Medicare-enrolled provider, Vann has provided services to 2,246 Medicare beneficiaries, totaling 2,376 services with total Medicare billing of $167,429. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Wakefield, MA
- Active Since 09/12/2011
- Last Updated 12/12/2024
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1902188477
Products in Payments
- ULTRA (Device) $464.33
- RESTASIS (Drug) $233.57
- XIIDRA (Drug) $155.58
- AIR OPTIX (Device) $121.90
- Multiple Brands Contact Lens (Device) $94.68
- TEPEZZA (Drug) $65.48
- TEPEZZA (Biological) $50.41
- VUITY (Drug) $40.20
- Acuvue (Device) $32.28
- LUMIGAN (Drug) $28.35
- Cequa (Drug) $26.11
- Rhopressa (Drug) $19.06
- Rocklatan (Drug) $16.62
- DAILIES (Device) $15.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Wakefield
Adam Grimm, O.d, O.D
Optometrist — Payments: $3,556
Optometrist $3,556
Dr. Rita Cherian, O.d, O.D
Optometrist — Payments: $3,277
Optometrist $3,277
Dr. Fei Siu, Od, OD
Optometrist — Payments: $2,364
Optometrist $2,364
Dr. Peter Violette, Od, OD
Optometrist — Payments: $1,845
Optometrist $1,845
Dr. Kristen Burns
Optometrist — Payments: $1,832
Optometrist $1,832
Nicole Fantoni, O.d, O.D
Optometrist — Payments: $1,420
Optometrist $1,420